Fundraising FoxSciFluor Life Sciences
Boston, US · Delaware corporation · 2 known investors
Find your way into SciFluor Life Sciences
Sign up to see every warm intro you have to SciFluor Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SciFluor Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DS
D. Scott EdwardsNamed on SEC filing
WH
William H. KosterNamed on SEC filing
RD
Robert DempseyNamed on SEC filing
MT
Michael TurnerNamed on SEC filing
JP
Joseph PignatoNamed on SEC filing
Investors · 2
InvescoreportedAtlanta
How we know: funding news · Not right? Tell us
Woodford Investment ManagementreportedOxford
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$57.2M disclosed across 2 of 3 rounds · 2019–2023
▶$25.6MraisedFeb 2024 · 279 investors · OtherRule 506(b)
▶$25.6MraisedFeb 2024 · 279 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kerrie BradyExecutive Officer, Director
- D. Scott EdwardsExecutive Officer
- Robin SteeleDirector
- David J. TanzerExecutive Officer
- William H. KosterDirector
- Bruce FailingDirector
- Barbara RyanDirector
- Brenton SaundersDirector
- Robert RuffoloDirector
- William SteinkraussExecutive Officer
- Offering amount
- $25.6M
- Amount sold
- $25.6M
- Sales commissions
- $2.6M
- Placement agents
- Maxim Group LLC
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31.5MraisedAug 2021 · 226 investors · PharmaceuticalsRule 506(b)
▶$31.5MraisedAug 2021 · 226 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robin SteeleDirector
- Robert RuffoloDirector
- Robert DempseyDirector
- Kerrie BradyExecutive Officer, Director
- Brent SaundersDirector
- David Scott EdwardsExecutive Officer, Promoter
- William H. KosterDirector
- Offering amount
- $50M
- Amount sold
- $31.5M
- Sales commissions
- $4.9M
- Proceeds to insiders
- $5.5M
- Placement agents
- Maxim Group LLC
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MofferedSep 2019 · PharmaceuticalsRule 506(b)
▶$1.5MofferedSep 2019 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- D. Scott EdwardsExecutive Officer, Promoter
- William H. KosterDirector
- Robert DempseyDirector
- Michael TurnerDirector
- Joseph PignatoDirector
- Offering amount
- $1.5M
- Sales commissions
- $150K
- Proceeds to insiders
- $150K
- Placement agents
- Maxim Group LLC
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are SciFluor Life Sciences's investors?
- SciFluor Life Sciences's investors include Invesco, Woodford Investment Management.
- How much funding has SciFluor Life Sciences raised?
- SciFluor Life Sciences has disclosed $57.2M raised across 2 of its 3 known rounds.
- Where is SciFluor Life Sciences headquartered?
- SciFluor Life Sciences is headquartered in Boston, US.